Publications 2021

Rognli EB, Aas EM, Drake RE, Marsden J, Anders P, Bond GR, Lystad JU, Reme SE, Arnevik EA (2021)
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help
Trials, 22 (1), 705
DOI 10.1186/s13063-021-05673-z

Publications 2020

Bukten A, Lund IO, Kinner SA, Rognli EB, Havnes IA, Muller AE, Stavseth MR (2020)
Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study
Health Justice, 8 (1), 10
DOI 10.1186/s40352-020-00112-8

Havnes IA, Bukten A, Rognli EB, Muller AE (2020)
Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study
Drug Alcohol Depend., 217, 108255
DOI 10.1016/j.drugalcdep.2020.108255

Rognli EB, Bramness JG, von Soest T (2020)
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Acta Psychiatr. Scand., 141 (2), 149-156
DOI 10.1111/acps.13104

Publications 2018

Muller AE, Havnes IA, Rognli EB, Bukten A (2018)
Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration
Int. J. Environ. Res. Public Health, 15 (12), 2663
DOI 10.3390/ijerph15122663

Ringen PA, Faerden A, Antonsen B, Falk RS, Mamen A, Rognli EB, Solberg DK, Andreassen OA, Martinsen EW (2018)
Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments
Nord. J. Psychiatr., 72 (4), 296-302
DOI 10.1080/08039488.2018.1449012

Ringen PA, Falk RS, Antonsen B, Faerden A, Mamen A, Rognli EB, Solberg DK, Martinsen EW, Andreassen OA (2018)
Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: a naturalistic interventional study
BMC Psychiatry, 18, 255
DOI 10.1186/s12888-018-1832-6

Publications 2017

Rognli EB, Bramness JG, Skurtveit S, Bukten A (2017)
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
J. Subst. Abus. Treat., 74, 42-47
DOI 10.1016/j.jsat.2016.12.007

Publications 2016

Bramness JG, Rognli EB (2016)
Psychosis induced by amphetamines
Curr. Opin. Psychiatr., 29 (4), 236-241
DOI 10.1097/YCO.0000000000000254

Publications 2015

Bukten A, Lund IO, Rognli EB, Stavseth MR, Lobmaier P, Skurtveit S, Clausen T, Kunoe N (2015)
The Norwegian Offender Mental Health and Addiction Study - Design and Implementation of a National Survey and Prospective Cohort Study
Subst. Abus.-Res. Treat., 9 2, 59-66
DOI 10.4137/SART.S23546

Medhus S, Rognli EB, Gossop M, Holm B, Morland J, Bramness JG (2015)
Amphetamine-Induced Psychosis: Transition to Schizophrenia and Mortality in a Small Prospective Sample
Am. J. Addict., 24 (7), 586-589
DOI 10.1111/ajad.12274

Rognli EB, Berge J, Hakansson A, Bramness JG (2015)
Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users
Schizophr. Res., 168 (1-2), 185-190
DOI 10.1016/j.schres.2015.08.032

Rognli EB, Medhus SE, Bramness JG (2015)
Amphetamine induced psychosis or schizophrenia?
Tidsskr. Nor. Laegeforen., 135 (3), 249-251
DOI 10.4045/tidsskr.14.1365

Publications 2014

Rognli EB, Hakansson A, Berge J, Bramness JG (2014)
Does the pattern of amphetamine use prior to incarceration predict later psychosis?-A longitudinal study of amphetamine users in the Swedish criminal justice system
Drug Alcohol Depend., 143, 219-224
DOI 10.1016/j.drugalcdep.2014.07.037

Publications 2012

Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Loberg EM, Medhus S, Tanum L, Franck J (2012)
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
BMC Psychiatry, 12, 221
DOI 10.1186/1471-244X-12-221